Zobrazeno 1 - 10
of 235
pro vyhledávání: '"Ichiro Fujiwara"'
Autor:
Masaharu Tamaki, Yu Akahoshi, Masahiro Ashizawa, Yukiko Misaki, Satoshi Koi, Sung-Won Kim, Yukiyasu Ozawa, Shin-ichiro Fujiwara, Shinichi Kako, Ken-ichi Matsuoka, Masashi Sawa, Yuta Katayama, Makoto Onizuka, Yoshinobu Kanda, Takahiro Fukuda, Yoshiko Atsuta, Kimikazu Yakushijin, Hideki Nakasone
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-10 (2023)
Abstract Allogeneic hematopoietic cell transplantation between female donors and male recipients (female-to-male allo-HCT) is a well-established risk factor for inferior survival outcomes due to a higher incidence of graft-versus-host disease (GVHD).
Externí odkaz:
https://doaj.org/article/854cda6ed879453093573fa734c2550c
Autor:
Shun-ichi Kimura, Yoshinobu Kanda, Masaki Iino, Takahiro Fukuda, Emiko Sakaida, Tatsuo Oyake, Hiroki Yamaguchi, Shin-ichiro Fujiwara, Yumi Jo, Akinao Okamoto, Hiroyuki Fujita, Yasushi Takamatsu, Yoshio Saburi, Itaru Matsumura, Jun Yamanouchi, Souichi Shiratori, Moritaka Gotoh, Shingen Nakamura, Kazuo Tamura
Publikováno v:
International Journal of Infectious Diseases, Vol 100, Iss , Pp 292-297 (2020)
Objectives: The D-index is defined as the area over the neutrophil curve during neutropenia. The CEDMIC trial confirmed the noninferiority of D-index-guided early antifungal therapy (DET) using micafungin to empirical antifungal therapy (EAT). In thi
Externí odkaz:
https://doaj.org/article/56f4329c4ebd413babece8f6dcdd5914
Autor:
Chihiro Yamamoto, Hirotomo Nakashima, Takashi Ikeda, Shin-ichiro Kawaguchi, Yumiko Toda, Shoko Ito, Kiyomi Mashima, Takashi Nagayama, Kento Umino, Daisuke Minakata, Hirofumi Nakano, Kaoru Morita, Ryoko Yamasaki, Miyuki Sugimoto, Yuko Ishihara, Masahiro Ashizawa, Kaoru Hatano, Kazuya Sato, Iekuni Oh, Shin-ichiro Fujiwara, Masuzu Ueda, Ken Ohmine, Kazuo Muroi, Yoshinobu Kanda
Publikováno v:
Blood Advances, Vol 3, Iss 21, Pp 3266-3277 (2019)
Abstract: The cost of tyrosine kinase inhibitors (TKIs) in the treatment of chronic myeloid leukemia (CML) is a substantial economic burden. In Japan, imatinib, dasatinib, and nilotinib are now approved as first-line treatment of CML in chronic phase
Externí odkaz:
https://doaj.org/article/457d89f637d1478bad0cfb53f35c1dde
Autor:
Kiyomi Mashima, Iekuni Oh, Ken Fujiwara, Junko Izawa, Norihito Takayama, Hirofumi Nakano, Yasufumi Kawasaki, Daisuke Minakata, Ryoko Yamasaki, Kaoru Morita, Masahiro Ashizawa, Chihiro Yamamoto, Kaoru Hatano, Kazuya Sato, Ken Ohmine, Shin-Ichiro Fujiwara, Nobuhiko Ohno, Yoshinobu Kanda
Publikováno v:
PLoS ONE, Vol 16, Iss 1, p e0245232 (2021)
Graft-versus-host disease is a major complication after allogeneic hematopoietic stem cell transplantation for hematological malignancies. Immunosuppressive drugs, such as anti-thymocyte globulin, alemtuzumab, and post-transplant cyclophosphamide, ha
Externí odkaz:
https://doaj.org/article/0aaa237dce9444c39147d32e9e85fd09
Autor:
Junya Kanda MD, PhD, Toshihiko Ando MD, PhD, Shun-ichi Kimura MD, PhD, Shin-ichiro Fujiwara MD, PhD, Kazunori Imada MD, PhD, Shin Fujisawa MD, PhD, Takayoshi Tachibana MD, PhD, Yoshiko Atsuta MD, PhD, Yoshinobu Kanda MD, PhD
Publikováno v:
Cell Transplantation, Vol 29 (2020)
Hematopoietic stem cell transplantation (HSCT) from a related donor with an human leukocyte antigen (HLA) 1-antigen mismatch without in vivo T cell depletion is associated with an elevated risk of severe, acute, and chronic graft-versus-host (GVH) di
Externí odkaz:
https://doaj.org/article/5f97fe8a39224d8ea9a31d657e974dd2
Autor:
Daisuke Minakata, Shin‐ichiro Fujiwara, Daizo Yokoyama, Atsuto Noguchi, Shuka Aoe, Takashi Oyama, Shunsuke Koyama, Rui Murahashi, Hirotomo Nakashima, Kazuki Hyodo, Takashi Ikeda, Shin‐ichiro Kawaguchi, Yumiko Toda, Shoko Ito, Takashi Nagayama, Kiyomi Mashima, Kento Umino, Kaoru Morita, Masahiro Ashizawa, Chihiro Yamamoto, Kaoru Hatano, Kazuya Sato, Ken Ohmine, Yoshinobu Kanda
Publikováno v:
British Journal of Haematology. 200:694-703
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0c8afa6c05df768d25d463a108aa748b
https://doi.org/10.1111/bjh.18654
https://doi.org/10.1111/bjh.18654
Autor:
Hirohito Kobayashi, Kimikazu Yakushijin, Masahiro Anan, Kazuhiko Ikeda, Yoshiki Okuyama, Shin-ichiro Fujiwara, Hitoshi Kanno, Ryuji Tanosaki, Takayuki Nakayama, Tokiko Nagamura-Inoue
Publikováno v:
Japanese Journal of Transfusion & Cell Therapy / Nihon Yuketsu Saibo Chiryo Gakkaishi; 2024, Vol. 70 Issue 1, p12-19, 8p
Risk factors for CAR‐T cell manufacturing failure among DLBCL patients: A nationwide survey in Japan
Autor:
Tomoyasu Jo, Satoshi Yoshihara, Yoshiki Okuyama, Keiko Fujii, Tomoko Henzan, Kaoru Kahata, Rie Yamazaki, Wataru Takeda, Yoshihiro Umezawa, Kentaro Fukushima, Takashi Ashida, Minami Yamada‐Fujiwara, Ryo Hanajiri, Noboru Yonetani, Yuma Tada, Yuji Shimura, Hidekazu Nishikii, Norio Shiba, Naoya Mimura, Jun Ando, Takayuki Sato, Yasuhiro Nakashima, Junko Ikemoto, Keita Iwaki, Shin‐ichiro Fujiwara, Masaki Ri, Tokiko Nagamura‐Inoue, Ryuji Tanosaki, Yasuyuki Arai
Publikováno v:
British Journal of Haematology.
For successful chimeric antigen receptor T (CAR-T) cell therapy, CAR-T cells must be manufactured without failure caused by suboptimal expansion. In order to determine risk factors for CAR-T cell manufacturing failure, we performed a nationwide cohor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4510dea0235b034671841fcea67d60e4
https://doi.org/10.1111/bjh.18831
https://doi.org/10.1111/bjh.18831
Autor:
Kazuhiko Ikeda, Keiji Minakawa, Kenichi Yamahara, Minami Yamada‐Fujiwara, Yoshiki Okuyama, Shin‐ichiro Fujiwara, Rie Yamazaki, Heiwa Kanamori, Tohru Iseki, Tokiko Nagamura‐Inoue, Kazuaki Kameda, Kazuhiro Nagai, Nobuharu Fujii, Takashi Ashida, Asao Hirose, Tsutomu Takahashi, Hitoshi Ohto, Koki Ueda, Ryuji Tanosaki
Publikováno v:
Transfusion. 62:1280-1288
The standard cryoprotectant for human cellular products is dimethyl sulfoxide (DMSO), which is associated with hematopoietic cell infusion-related adverse events (HCI-AEs) in hematopoietic stem cell transplantation including peripheral blood stem cel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba916318d36c50c4cd410c691ba3897f
https://doi.org/10.1111/trf.16877
https://doi.org/10.1111/trf.16877
Autor:
Kimikazu Yakushijin, Satoshi Yoshihara, Junko Ikemoto, Kazuhiko Ikeda, Akaru Ishida, Hitoshi Ohto, Akira Ohara, Michiko Kajiwara, Atsushi Kikuta, Kyoko Haraguchi, Shin-ichiro Fujiwara, Minami Yamada-Fujiwara, Rie Yamazaki, Tokiko Nagamura-Inoue, Ryuji Tanosaki, Yoshiki Okuyama, Yoshihiro Fujimori, Yasunori Ueda
Publikováno v:
Japanese Journal of Transfusion & Cell Therapy / Nihon Yuketsu Saibo Chiryo Gakkaishi; 2023, Vol. 69 Issue 6, p641-647, 7p